SCHEMBL4443579

SCHEMBL4443579

CNS(=O)(=O)c1cccc(C(C)CCC(CCc2ccccc2)C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
AKR1C3 P42330 1/20 0.42
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
MMP14 P50281 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1856429 0.85 POLB (0.51) POLBALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL4571000 0.85 POLB (0.48) POLBALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL1856417 0.78 MMP2 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19MMP1
SCHEMBL1857442 0.77 CPA3 (0.49) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL1859707 0.75 POLB (0.53) POLBALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL8039484 0.72 HTR6 (0.58) HDAC8HDAC2HDAC6MMP1MMP2
SCHEMBL1861591 0.72 HDAC2 (0.52) POLBALDH1A1CYP1A2L3MBTL1AKR1C3
SCHEMBL1857365 0.71 CYP1A2 (0.61) CYP1A2
SCHEMBL1857400 0.71 POLB (0.49) POLBALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL18713706 0.71 HDAC4 (0.50) L3MBTL1LMNASMN1; SMN2HDAC8HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed